Clinical

Dataset Information

0

Phase II study of Panitunumab plus Cetuximab in pretreated in patients with metastatic colorectal cancer


ABSTRACT: Primary objectives: Assess the efficacy of panitumumab in combination with Trifluridine- Tipiracile vs standard third line therapy (Trifluridine-Tipiracile) as measured by PFS Primary endpoints: PFS: defined as the time from randomization to the earliest documented disease progression or death due to any cause

DISEASE(S): Mcrc,Tumore Del Colon-retto Metastatico,Gastrointestinal Neoplasms Malignant And Unspecified

PROVIDER: 2538100 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2541579 | ecrin-mdr-crc
| 2401536 | ecrin-mdr-crc
| 2742553 | ecrin-mdr-crc
| 2538002 | ecrin-mdr-crc
2024-03-01 | GSE225043 | GEO
2019-01-23 | GSE102995 | GEO
| 2528754 | ecrin-mdr-crc
| 2537370 | ecrin-mdr-crc
2014-09-03 | GSE56701 | GEO
2017-09-25 | GSE96786 | GEO